Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
Fate Therapeutics Bags $30M Venture Deal, Led by OVP, to Develop “Industrialized” Stem Cells
|
Luke Timmerman |
11/16/09 |
National
|
|
Aileron’s New Class of Drugs Shown to Get Inside Cells to Block Prime Cancer Target
|
Luke Timmerman |
11/11/09 |
Boston
|
|
Ion Torrent, Stealthy Company Tied to Harvard’s George Church, Nabs $23M Venture Deal
|
Luke Timmerman |
11/06/09 |
Boston
|
|
Microsoft’s Craig Mundie on Future Interfaces, Computer Science Education, and Life After Bill G
|
Gregory T. Huang |
11/04/09 |
Seattle
|
|
UW Scientists, Backed by Gates Foundation, Enter “Put Up or Shut Up” Phase with Portable Diagnostic
|
Luke Timmerman |
11/03/09 |
Seattle
|
|
Harvard to Buy Wind Power
|
Wade Roush |
11/02/09 |
Boston
|
|
Pulmatrix Scores $30M To Block All Sorts of Bugs That Make People Sick in the Lungs
|
Luke Timmerman |
11/02/09 |
Boston
|
|
Faster, Cheaper Stem Cells: Fate Therapeutics Co-Founder, With Scripps Team, Finds Key
|
Luke Timmerman |
10/18/09 |
National
|
|
Merrimack Pharma Grabs $60M Upfront From Sanofi for Cancer Antibody
|
Luke Timmerman |
10/01/09 |
Boston
|
|
Recruit Rock Star Scientists To Make Seattle Thrive as an Innovation Hub
|
Carl Weissman |
10/01/09 |
Seattle
|
|
Former Harvard Official Tapped to Expand Tech Transfer at Brown U.
|
Ryan McBride |
10/01/09 |
Boston
|
|
Fate Therapeutics Growing Fast on “Industrialized” Stem Cell Technology
|
Luke Timmerman |
09/30/09 |
National
|
|
Biogen Idec Faces Suit From Partner Elan, Genzyme Wins European Approval for Stem-Cell Boosting Drug, Alnylam Teams with Tekmira, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
08/12/09 |
Boston
|
|
Biotech Startup Acetylon Pharma Catches $7.25M in A Round from Backers Such As New England Patriots Owner
|
Ryan McBride |
08/07/09 |
Boston
|
|
Clarus Leans on Customer Reviews at the Broad Institute to Bet on NanoString
|
Luke Timmerman |
07/29/09 |
Boston
|
|
Global Health Funding Booms, But Not Just From Gates, UW-Harvard Study Finds
|
Luke Timmerman |
06/18/09 |
Seattle
|
|
Pulmatrix, With One Drug for Multiple Bugs, Aims to Fundamentally Change Flu Treatment
|
Luke Timmerman |
06/09/09 |
Boston
|
|
Aileron Snags $40M From Quartet of Pharma Giants to Develop New Class of Drugs
|
Luke Timmerman |
06/08/09 |
Boston
|
|
Dartmouth Biz Plan Competition Elevates Novoculi, Developer of Non-Invasive Diabetes Test
|
Ryan McBride |
05/21/09 |
Boston
|
|
Google, Microsoft May Help Usher in Personalized Medicine Wave, Says George Church
|
Luke Timmerman |
05/12/09 |
Boston
|
|
Life Technologies, Geospiza Form Cloud Computing Deal for Scientists to Dig Into Genome
|
Luke Timmerman |
04/28/09 |
Seattle
|
|
Obama’s Science and Technology Advisory Council Includes Holdren, Molina, Mundie
|
Gregory T. Huang |
04/27/09 |
National
|
|
Obama Stimulus Plan May Generate $300M Research Windfall, UW Says
|
Luke Timmerman |
03/23/09 |
Seattle
|
|
Stemgent Nails Down $14M to Make Supplies, Tools for Stem Cell Researchers
|
Luke Timmerman |
03/09/09 |
Boston
|
|
Surface Logix, Developer of Obesity and Diabetes Drugs, Nabs $20M Financing
|
Luke Timmerman |
03/09/09 |
Boston
|
|
Life Sciences on a Budget: Startups Make Pitch for Angel Dollars at First Zino Society Forum
|
Luke Timmerman |
02/25/09 |
Seattle
|
|
EMC, MIT Led Bay State Patent Winners in 2008—Here’s the Top 25 List
|
Ryan McBride |
01/23/09 |
Boston
|
|
Yale Endowment Down 25 Percent
|
Ryan McBride |
12/17/08 |
Boston
|
|
Ariad CEO Fires Back at Resigning Directors and Their “False and Misleading” Attacks
|
Luke Timmerman |
12/08/08 |
Boston
|
|
Harvard Endowment Down $8B, Further Losses Expected
|
Ryan McBride |
12/03/08 |
Boston
|
|
Page 1 of
2 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
